315 related articles for article (PubMed ID: 34157192)
21. Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity.
Zhang Y; Chen G; Liu Z; Tian S; Zhang J; Carey CD; Murphy KM; Storkus WJ; Falo LD; You Z
J Immunol; 2015 Jun; 194(12):5937-47. PubMed ID: 25972487
[TBL] [Abstract][Full Text] [Related]
22. CD103+ Dendritic Cells Elicit CD8+ T Cell Responses to Accelerate Kidney Injury in Adriamycin Nephropathy.
Cao Q; Lu J; Li Q; Wang C; Wang XM; Lee VW; Wang C; Nguyen H; Zheng G; Zhao Y; Alexander SI; Wang Y; Harris DC
J Am Soc Nephrol; 2016 May; 27(5):1344-60. PubMed ID: 26376858
[TBL] [Abstract][Full Text] [Related]
23. Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma.
Kim BR; Yang EK; Kim DY; Kim SH; Moon DC; Lee JH; Kim HJ; Lee JC
Clin Exp Immunol; 2012 Jan; 167(1):73-83. PubMed ID: 22132887
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
[TBL] [Abstract][Full Text] [Related]
25. Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103
Zhou Y; Slone N; Chrisikos TT; Kyrysyuk O; Babcock RL; Medik YB; Li HS; Kleinerman ES; Watowich SS
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32273347
[TBL] [Abstract][Full Text] [Related]
26. Intestinal CD103(-) dendritic cells migrate in lymph and prime effector T cells.
Cerovic V; Houston SA; Scott CL; Aumeunier A; Yrlid U; Mowat AM; Milling SW
Mucosal Immunol; 2013 Jan; 6(1):104-13. PubMed ID: 22718260
[TBL] [Abstract][Full Text] [Related]
27. Immunization with short peptide particles reveals a functional CD8
He X; Zhou S; Dolan M; Shi Y; Wang J; Quinn B; Jahagirdar D; Huang WC; Tsuji M; Pili R; Ito F; Ortega J; Abrams SI; Ebos JML; Lovell JF
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34862254
[TBL] [Abstract][Full Text] [Related]
28. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-β.
Yu CI; Becker C; Wang Y; Marches F; Helft J; Leboeuf M; Anguiano E; Pourpe S; Goller K; Pascual V; Banchereau J; Merad M; Palucka K
Immunity; 2013 Apr; 38(4):818-30. PubMed ID: 23562160
[TBL] [Abstract][Full Text] [Related]
29. Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation.
Wang R; Chen T; Wang C; Zhang Z; Wang XM; Li Q; Lee VWS; Wang YM; Zheng G; Alexander SI; Wang Y; Harris DCH; Cao Q
Nephrol Dial Transplant; 2019 Nov; 34(11):1853-1863. PubMed ID: 30590794
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells alleviate rat diabetic nephropathy by suppressing CD103
Zhang F; Wang C; Wen X; Chen Y; Mao R; Cui D; Li L; Liu J; Chen Y; Cheng J; Lu Y
J Cell Mol Med; 2020 May; 24(10):5817-5831. PubMed ID: 32283569
[TBL] [Abstract][Full Text] [Related]
31. A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
Faiena I; Comin-Anduix B; Berent-Maoz B; Bot A; Zomorodian N; Sachdeva A; Said J; Cheung-Lau G; Pang J; Macabali M; Chodon T; Wang X; Cabrera P; Kaplan-Lefko P; Chamie K; Belldegrun AS; Pantuck AJ; Drakaki A
J Immunother; 2020; 43(9):273-282. PubMed ID: 32925563
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
[TBL] [Abstract][Full Text] [Related]
33. Small molecule AZD4635 inhibitor of A
Borodovsky A; Barbon CM; Wang Y; Ye M; Prickett L; Chandra D; Shaw J; Deng N; Sachsenmeier K; Clarke JD; Linghu B; Brown GA; Brown J; Congreve M; Cheng RK; Dore AS; Hurrell E; Shao W; Woessner R; Reimer C; Drew L; Fawell S; Schuller AG; Mele DA
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727810
[TBL] [Abstract][Full Text] [Related]
34. Immunostimulatory activity of dendritic cells pulsed with carbonic anhydrase IX and Acinetobacter baumannii outer membrane protein A for renal cell carcinoma.
Kim BR; Yang EK; Kim SH; Moon DC; Kim HJ; Lee JC; Kim DY
J Microbiol; 2011 Feb; 49(1):115-20. PubMed ID: 21369988
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic efficacy of dendritic cells pulsed by autologous tumor cell lysate in combination with CIK cells on advanced renal cell carcinoma].
Wang H; Feng F; Zhu M; Wang R; Wang X; Wu Y; Zhuang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):67-71. PubMed ID: 25575061
[TBL] [Abstract][Full Text] [Related]
36. Transcutaneous immunization with a highly active form of XCL1 as a vaccine adjuvant using a hydrophilic gel patch elicits long-term CD8
Kamei M; Matsuo K; Imanishi H; Hara Y; Quen YS; Kamiyama F; Oiso N; Kawada A; Okada N; Nakayama T
J Pharmacol Sci; 2020 Jul; 143(3):182-187. PubMed ID: 32386904
[TBL] [Abstract][Full Text] [Related]
37. The closely related CD103+ dendritic cells (DCs) and lymphoid-resident CD8+ DCs differ in their inflammatory functions.
Jiao Z; Bedoui S; Brady JL; Walter A; Chopin M; Carrington EM; Sutherland RM; Nutt SL; Zhang Y; Ko HJ; Wu L; Lew AM; Zhan Y
PLoS One; 2014; 9(3):e91126. PubMed ID: 24637385
[TBL] [Abstract][Full Text] [Related]
38. Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma.
Laurell A; Lönnemark M; Brekkan E; Magnusson A; Tolf A; Wallgren AC; Andersson B; Adamson L; Kiessling R; Karlsson-Parra A
J Immunother Cancer; 2017; 5():52. PubMed ID: 28642820
[TBL] [Abstract][Full Text] [Related]
39. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
40. CD103
Xiao Y; Li H; Mao L; Yang QC; Fu LQ; Wu CC; Liu B; Sun ZJ
J Dent Res; 2019 Dec; 98(13):1480-1487. PubMed ID: 31658426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
